Current Report Filing (8-k)
August 20 2020 - 8:42AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported): August 19, 2020
Blonder Tongue Laboratories, Inc.
(Exact Name of registrant as
specified in its charter)
Delaware
|
|
1-14120
|
|
52-1611421
|
(State or other jurisdiction
|
|
(Commission File Number)
|
|
(I.R.S. Employer
|
of incorporation)
|
|
|
|
Identification No.)
|
One Jake Brown Road, Old Bridge, New
Jersey 08857
(Address of principal executive
offices) (Zip Code)
Registrant’s telephone number,
including area code: (732) 679-4000
Not Applicable
(Former name or former address,
if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
|
Trading symbol(s)
|
|
Name of each exchange on which registered
|
Common Stock, par value $.001
|
|
BDR
|
|
NYSE American
|
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01
|
Regulation FD Disclosure.
|
On August 19, 2020, Blonder Tongue Laboratories, Inc. (the “Company”)
issued a press release providing comments on recent trading activity in the Company’s common stock. A copy of the press release
is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.
On August 20, 2020, the Company issued a press release relating
to its continuing activities to reduce costs and preserve working capital and liquidity. A copy of the press release is attached
to this Current Report on Form 8-K as Exhibit 99.2 and is incorporated herein by reference.
The information in this Item 7.01, including Exhibits 99.1 and
99.2, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”), or otherwise subject to the liabilities under that Section, and shall not be deemed incorporated
by reference into any of the Company’s reports or filings under the Securities Act of 1933, as amended, or the Exchange Act, whether
made before or after the date hereof, except as expressly set forth by specific reference in such report or filing. The inclusion
of this Item 7.01 in this Current Report on Form 8-K, including Exhibits 99.1 and 99.2 attached hereto, shall not be deemed an
admission as to the materiality of any information herein.
Item 9.01
|
Financial Statements and Exhibits
|
(d)
|
Exhibits. The following exhibits are filed herewith:
|
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
BLONDER TONGUE LABORATORIES, INC.
|
|
|
|
|
By:
|
/s/ Eric Skolnik
|
|
Eric Skolnik
|
|
Senior Vice President and Chief Financial Officer
|
Date: August 20, 2020
2
Blonder Tongue Laborator... (AMEX:BDR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Blonder Tongue Laborator... (AMEX:BDR)
Historical Stock Chart
From Apr 2023 to Apr 2024